Literature DB >> 22478856

Resurrection of preterm labor drug evokes questions of fairness.

Tom Morrow.   

Abstract

Big prices for small-market biopharmaceuticals is nothing new. But when the market is centered around a public health concern, pricing can trigger contentious issues.

Entities:  

Year:  2011        PMID： 22478856      PMCID： PMC3138388     

Source DB:  PubMed          Journal:  Biotechnol Healthc        ISSN： 1554-169X


  3 in total

1.  Ovarian surgery with loss of corpus luteum in early pregnancy. Report of two cases brought to term with progestin (Delautin) therapy.

Authors:  I D MACINTYRE
Journal:  Can Med Assoc J       Date:  1961-07-08       Impact factor: 8.262

2.  Progestogen administration in pregnancy may prevent preterm delivery.

Authors:  M J Keirse
Journal:  Br J Obstet Gynaecol       Date:  1990-02

3.  Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate.

Authors:  Paul J Meis; Mark Klebanoff; Elizabeth Thom; Mitchell P Dombrowski; Baha Sibai; Atef H Moawad; Catherine Y Spong; John C Hauth; Menachem Miodovnik; Michael W Varner; Kenneth J Leveno; Steve N Caritis; Jay D Iams; Ronald J Wapner; Deborah Conway; Mary J O'Sullivan; Marshall Carpenter; Brian Mercer; Susan M Ramin; John M Thorp; Alan M Peaceman; Steven Gabbe
Journal:  N Engl J Med       Date:  2003-06-12       Impact factor: 91.245
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.